DSIP is under active research for potential application in: Individuals with insomnia or light, fragmented sleep Those with chronic stress or HPA axis dysfunction Athletes and biohackers seeking enhanced recovery People working night shifts or experiencing circadian misalignment Adults with low growth hormone output or reduced sleep efficiency Patients with PTSD or trauma-related sleep disruption (research ongoing) DSIP is not FDA-approved for any medical condition and should only be used in research settings under supervision
RS-2021-NR060141 to B.-H.B.) and by the National Research Foundation of Korea funded by the Ministry of Science and ICT, Republic of Korea (grant nos
The Medicines and Healthcare products Regulatory Agency (MHRA) said it had taken action against seven clinics offering NAD+ for medicinal purposes, requiring them to remove treatment claims
By Steve Blechman BREAKING NEWS
Inductively Coupled PlasmaMass Spectrometry (ICPMS) For quantifying trace copper content, ICPMS provides unrivaled sensitivity down to parts-per-trillion
Neurological Fatigue: By reducing elevated ventricular lactate and supporting efficient mitochondrial ATP production in the brain, NAC helps alleviate the heavy, "weighted" feeling in the head often reported by patients
